| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoblasts | 24 | 2021 | 175 | 3.960 |
Why?
|
| Neurofibromatosis 1 | 12 | 2022 | 70 | 3.690 |
Why?
|
| Bone Remodeling | 13 | 2018 | 56 | 3.620 |
Why?
|
| Neurofibromin 1 | 9 | 2015 | 57 | 2.620 |
Why?
|
| Osteogenesis | 16 | 2018 | 181 | 2.580 |
Why?
|
| Bone and Bones | 15 | 2024 | 305 | 2.370 |
Why?
|
| Sympathetic Nervous System | 11 | 2015 | 51 | 2.330 |
Why?
|
| Osteoclasts | 10 | 2021 | 68 | 1.940 |
Why?
|
| Chondrocytes | 8 | 2021 | 48 | 1.770 |
Why?
|
| Bone Development | 5 | 2021 | 58 | 1.430 |
Why?
|
| Integrases | 2 | 2021 | 157 | 1.260 |
Why?
|
| Homeostasis | 9 | 2018 | 712 | 1.050 |
Why?
|
| Mice | 42 | 2024 | 18160 | 1.010 |
Why?
|
| Signal Transduction | 13 | 2017 | 4645 | 1.010 |
Why?
|
| Vestibule, Labyrinth | 3 | 2015 | 32 | 0.990 |
Why?
|
| Bone Diseases, Developmental | 4 | 2014 | 61 | 0.980 |
Why?
|
| Animals | 59 | 2024 | 33660 | 0.970 |
Why?
|
| Pseudarthrosis | 3 | 2015 | 8 | 0.940 |
Why?
|
| Intervertebral Disc | 2 | 2024 | 13 | 0.920 |
Why?
|
| Leptin | 7 | 2007 | 218 | 0.890 |
Why?
|
| Growth Plate | 6 | 2018 | 20 | 0.830 |
Why?
|
| NFATC Transcription Factors | 1 | 2024 | 39 | 0.820 |
Why?
|
| Cell Differentiation | 10 | 2021 | 1906 | 0.780 |
Why?
|
| Receptors, Adrenergic, beta-2 | 5 | 2021 | 57 | 0.770 |
Why?
|
| Bone Neoplasms | 4 | 2017 | 470 | 0.740 |
Why?
|
| Periodontal Ligament | 1 | 2021 | 2 | 0.700 |
Why?
|
| Osteoporosis | 3 | 2024 | 133 | 0.680 |
Why?
|
| Isoproterenol | 1 | 2021 | 85 | 0.680 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2021 | 79 | 0.670 |
Why?
|
| Bone Density | 8 | 2024 | 366 | 0.650 |
Why?
|
| Neurofibroma | 1 | 2020 | 7 | 0.650 |
Why?
|
| Neurofibroma, Plexiform | 1 | 2020 | 8 | 0.640 |
Why?
|
| Acetylcholine | 1 | 2020 | 69 | 0.620 |
Why?
|
| Tenascin | 4 | 2001 | 33 | 0.620 |
Why?
|
| Cell Lineage | 1 | 2021 | 340 | 0.580 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type III | 1 | 2018 | 6 | 0.580 |
Why?
|
| Calcification, Physiologic | 3 | 2014 | 24 | 0.560 |
Why?
|
| Mice, Knockout | 12 | 2024 | 3810 | 0.560 |
Why?
|
| Autonomic Nervous System | 1 | 2018 | 48 | 0.550 |
Why?
|
| Activating Transcription Factor 4 | 5 | 2011 | 34 | 0.550 |
Why?
|
| Bone Resorption | 5 | 2015 | 52 | 0.540 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2015 | 86 | 0.530 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 208 | 0.530 |
Why?
|
| Chondrogenesis | 2 | 2015 | 31 | 0.490 |
Why?
|
| Brain | 3 | 2020 | 3146 | 0.480 |
Why?
|
| ErbB Receptors | 1 | 2017 | 285 | 0.470 |
Why?
|
| Mice, Transgenic | 8 | 2021 | 2330 | 0.460 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2013 | 137 | 0.450 |
Why?
|
| Tibial Fractures | 2 | 2013 | 64 | 0.440 |
Why?
|
| Bone Regeneration | 1 | 2015 | 33 | 0.430 |
Why?
|
| Pyrimidinones | 1 | 2015 | 62 | 0.430 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2015 | 56 | 0.420 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2015 | 68 | 0.420 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2020 | 613 | 0.420 |
Why?
|
| Alkaline Phosphatase | 1 | 2014 | 94 | 0.420 |
Why?
|
| Lovastatin | 2 | 2011 | 24 | 0.410 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2013 | 6 | 0.400 |
Why?
|
| Pyridones | 1 | 2015 | 139 | 0.400 |
Why?
|
| Models, Animal | 4 | 2023 | 449 | 0.390 |
Why?
|
| Norepinephrine | 1 | 2013 | 148 | 0.390 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 525 | 0.390 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2013 | 57 | 0.380 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 56 | 0.370 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2014 | 688 | 0.370 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2012 | 235 | 0.350 |
Why?
|
| Adrenergic beta-Antagonists | 5 | 2024 | 216 | 0.350 |
Why?
|
| Collagen Type II | 5 | 2015 | 23 | 0.340 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 781 | 0.340 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 877 | 0.340 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 243 | 0.330 |
Why?
|
| NF-kappa B | 1 | 2013 | 439 | 0.330 |
Why?
|
| Bone Diseases | 2 | 2023 | 48 | 0.330 |
Why?
|
| Neurons | 5 | 2013 | 1978 | 0.320 |
Why?
|
| Stromal Cells | 1 | 2012 | 316 | 0.320 |
Why?
|
| Fracture Healing | 1 | 2010 | 31 | 0.320 |
Why?
|
| Receptors, Adrenergic, beta | 4 | 2013 | 42 | 0.320 |
Why?
|
| Hypothalamus | 3 | 2008 | 198 | 0.300 |
Why?
|
| Tibia | 5 | 2022 | 86 | 0.300 |
Why?
|
| Gene Expression Regulation | 4 | 2024 | 2322 | 0.290 |
Why?
|
| Glucocorticoids | 1 | 2011 | 345 | 0.280 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1800 | 0.280 |
Why?
|
| Peripheral Nervous System | 1 | 2008 | 44 | 0.270 |
Why?
|
| Neuropeptide Y | 2 | 2008 | 34 | 0.270 |
Why?
|
| Promoter Regions, Genetic | 3 | 2021 | 1207 | 0.260 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 1576 | 0.250 |
Why?
|
| Fractures, Bone | 2 | 2022 | 213 | 0.250 |
Why?
|
| Receptor, EphB4 | 1 | 2006 | 3 | 0.250 |
Why?
|
| Ephrin-B2 | 1 | 2006 | 9 | 0.250 |
Why?
|
| Neuropeptides | 3 | 2008 | 105 | 0.250 |
Why?
|
| X-Ray Microtomography | 5 | 2016 | 101 | 0.240 |
Why?
|
| Stem Cells | 1 | 2011 | 703 | 0.240 |
Why?
|
| Receptors, Neuropeptide | 1 | 2005 | 13 | 0.230 |
Why?
|
| Recombination, Genetic | 2 | 2021 | 422 | 0.230 |
Why?
|
| Periodontal Diseases | 2 | 2016 | 31 | 0.230 |
Why?
|
| Propranolol | 3 | 2015 | 110 | 0.220 |
Why?
|
| Blotting, Western | 3 | 2017 | 1014 | 0.220 |
Why?
|
| Dietary Proteins | 1 | 2006 | 222 | 0.220 |
Why?
|
| Humans | 29 | 2024 | 130055 | 0.220 |
Why?
|
| Osteocytes | 3 | 2014 | 19 | 0.220 |
Why?
|
| Cells, Cultured | 8 | 2017 | 2885 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2016 | 183 | 0.210 |
Why?
|
| Vestibular Diseases | 2 | 2015 | 67 | 0.210 |
Why?
|
| Osmotic Pressure | 1 | 2024 | 24 | 0.210 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 2004 | 25 | 0.210 |
Why?
|
| Sodium Glutamate | 1 | 2003 | 6 | 0.200 |
Why?
|
| Animal Experimentation | 1 | 2023 | 3 | 0.200 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2021 | 158 | 0.200 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2003 | 41 | 0.190 |
Why?
|
| ras Proteins | 2 | 2016 | 140 | 0.190 |
Why?
|
| Gene Deletion | 3 | 2013 | 766 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 2 | 2008 | 1076 | 0.190 |
Why?
|
| Disease Models, Animal | 6 | 2022 | 4639 | 0.190 |
Why?
|
| Heparin | 2 | 2001 | 205 | 0.190 |
Why?
|
| Female | 18 | 2024 | 70227 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 4691 | 0.190 |
Why?
|
| Transcription Factors | 3 | 2024 | 2400 | 0.190 |
Why?
|
| Cell Adhesion | 2 | 2001 | 308 | 0.180 |
Why?
|
| Cell Line | 5 | 2017 | 2554 | 0.180 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2021 | 324 | 0.180 |
Why?
|
| Pyrimidines | 2 | 2016 | 454 | 0.180 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2021 | 8 | 0.170 |
Why?
|
| Mice, Mutant Strains | 3 | 2014 | 354 | 0.170 |
Why?
|
| Proteoglycans | 1 | 2001 | 78 | 0.170 |
Why?
|
| Fibronectins | 1 | 2001 | 99 | 0.160 |
Why?
|
| Biological Transport, Active | 2 | 2013 | 70 | 0.160 |
Why?
|
| Organ Size | 3 | 2013 | 408 | 0.160 |
Why?
|
| Body Composition | 1 | 2003 | 543 | 0.160 |
Why?
|
| Schwann Cells | 1 | 2020 | 61 | 0.160 |
Why?
|
| Mice, Nude | 3 | 2017 | 699 | 0.150 |
Why?
|
| Hedgehog Proteins | 2 | 2011 | 198 | 0.150 |
Why?
|
| Gene Expression | 2 | 2015 | 1482 | 0.150 |
Why?
|
| Bone Matrix | 2 | 2022 | 8 | 0.150 |
Why?
|
| Amyloidogenic Proteins | 1 | 2019 | 7 | 0.150 |
Why?
|
| Integrins | 1 | 1999 | 89 | 0.150 |
Why?
|
| Dementia | 1 | 2024 | 435 | 0.150 |
Why?
|
| Collagen | 4 | 2016 | 274 | 0.140 |
Why?
|
| Amino Acids | 2 | 2015 | 564 | 0.140 |
Why?
|
| Aging | 2 | 2019 | 1238 | 0.140 |
Why?
|
| Cattle | 4 | 2001 | 500 | 0.140 |
Why?
|
| RNA, Messenger | 3 | 2017 | 2548 | 0.140 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 66 | 0.140 |
Why?
|
| Femur | 2 | 2015 | 79 | 0.140 |
Why?
|
| Neurofibromatoses | 1 | 2018 | 9 | 0.140 |
Why?
|
| Neurofibromatosis 2 | 1 | 2018 | 12 | 0.140 |
Why?
|
| Weight-Bearing | 1 | 2018 | 48 | 0.140 |
Why?
|
| Neoplasm Proteins | 2 | 2017 | 679 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2017 | 27 | 0.130 |
Why?
|
| Neurilemmoma | 1 | 2018 | 39 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2017 | 57 | 0.130 |
Why?
|
| Anilides | 1 | 2017 | 52 | 0.130 |
Why?
|
| Collagen Type I | 2 | 2015 | 110 | 0.130 |
Why?
|
| Osteocalcin | 3 | 2015 | 46 | 0.130 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 258 | 0.120 |
Why?
|
| Receptors, Leptin | 3 | 2005 | 40 | 0.120 |
Why?
|
| Pyridines | 1 | 2017 | 258 | 0.120 |
Why?
|
| Cell Line, Tumor | 4 | 2017 | 3713 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 227 | 0.120 |
Why?
|
| Guanidines | 1 | 2015 | 21 | 0.120 |
Why?
|
| RANK Ligand | 2 | 2006 | 51 | 0.120 |
Why?
|
| Ovariectomy | 1 | 2015 | 152 | 0.110 |
Why?
|
| Porosity | 2 | 2014 | 41 | 0.110 |
Why?
|
| RNA, Neoplasm | 1 | 2015 | 125 | 0.110 |
Why?
|
| Genes, Neurofibromatosis 1 | 1 | 2015 | 3 | 0.110 |
Why?
|
| Alu Elements | 1 | 2015 | 66 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2006 | 158 | 0.110 |
Why?
|
| Bone Transplantation | 1 | 2015 | 54 | 0.110 |
Why?
|
| Phenotype | 3 | 2015 | 4456 | 0.110 |
Why?
|
| Central Nervous System Stimulants | 1 | 2016 | 131 | 0.110 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2015 | 26 | 0.110 |
Why?
|
| Phenols | 1 | 2015 | 73 | 0.110 |
Why?
|
| Hypertrophy | 1 | 2015 | 99 | 0.110 |
Why?
|
| Serotonin | 1 | 2016 | 209 | 0.110 |
Why?
|
| Durapatite | 1 | 2014 | 9 | 0.110 |
Why?
|
| Sp7 Transcription Factor | 1 | 2014 | 5 | 0.110 |
Why?
|
| Phosphate Transport Proteins | 1 | 2014 | 5 | 0.110 |
Why?
|
| Diphosphates | 1 | 2014 | 8 | 0.110 |
Why?
|
| Body Weight | 4 | 2015 | 985 | 0.110 |
Why?
|
| Biofilms | 1 | 2015 | 92 | 0.110 |
Why?
|
| Phenylurea Compounds | 1 | 2015 | 57 | 0.110 |
Why?
|
| DNA, Neoplasm | 1 | 2015 | 282 | 0.110 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 131 | 0.110 |
Why?
|
| Pyrophosphatases | 1 | 2014 | 18 | 0.110 |
Why?
|
| Cell Proliferation | 4 | 2017 | 2462 | 0.110 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2014 | 62 | 0.110 |
Why?
|
| Lipodystrophy | 2 | 2004 | 37 | 0.100 |
Why?
|
| Mice, Obese | 2 | 2004 | 74 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2023 | 2891 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2015 | 589 | 0.100 |
Why?
|
| Protein Transport | 1 | 2015 | 365 | 0.100 |
Why?
|
| Binding Sites | 3 | 2001 | 1134 | 0.100 |
Why?
|
| Psychomotor Disorders | 1 | 2013 | 30 | 0.100 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 218 | 0.100 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2013 | 32 | 0.100 |
Why?
|
| Morpholines | 1 | 2013 | 66 | 0.100 |
Why?
|
| Skin | 3 | 2001 | 538 | 0.100 |
Why?
|
| I-kappa B Proteins | 1 | 2013 | 36 | 0.100 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2016 | 246 | 0.100 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 229 | 0.100 |
Why?
|
| Amino Acid Sequence | 3 | 2005 | 2392 | 0.100 |
Why?
|
| Acetylation | 1 | 2013 | 191 | 0.090 |
Why?
|
| Organ Specificity | 1 | 2013 | 394 | 0.090 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2016 | 468 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 378 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2015 | 299 | 0.090 |
Why?
|
| Prednisolone | 1 | 2011 | 73 | 0.080 |
Why?
|
| Gene Targeting | 1 | 2011 | 169 | 0.080 |
Why?
|
| Antidepressive Agents | 1 | 2013 | 319 | 0.080 |
Why?
|
| Bony Callus | 1 | 2010 | 4 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 903 | 0.080 |
Why?
|
| Transgenes | 1 | 2011 | 316 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 2076 | 0.080 |
Why?
|
| Oligopeptides | 3 | 2002 | 101 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2011 | 576 | 0.080 |
Why?
|
| Cyclic AMP | 1 | 2011 | 221 | 0.080 |
Why?
|
| Animals, Newborn | 2 | 2011 | 1019 | 0.080 |
Why?
|
| Sphenoid Bone | 1 | 2009 | 8 | 0.080 |
Why?
|
| Prostatic Neoplasms | 1 | 2017 | 1404 | 0.080 |
Why?
|
| Dexamethasone | 1 | 2011 | 249 | 0.070 |
Why?
|
| Male | 9 | 2024 | 64375 | 0.070 |
Why?
|
| Vimentin | 1 | 2009 | 59 | 0.070 |
Why?
|
| Disease Progression | 1 | 2015 | 2191 | 0.070 |
Why?
|
| Thoracic Wall | 1 | 2009 | 40 | 0.070 |
Why?
|
| Transcription, Genetic | 2 | 2014 | 1363 | 0.070 |
Why?
|
| Cell Movement | 1 | 2012 | 873 | 0.070 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 2008 | 8 | 0.070 |
Why?
|
| Kinetics | 2 | 2001 | 1087 | 0.070 |
Why?
|
| Calcitonin | 1 | 2008 | 27 | 0.070 |
Why?
|
| Child | 4 | 2016 | 26171 | 0.070 |
Why?
|
| Receptor, Melanocortin, Type 4 | 2 | 2005 | 28 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 1453 | 0.070 |
Why?
|
| Coffin-Lowry Syndrome | 1 | 2006 | 3 | 0.060 |
Why?
|
| Breast Neoplasms | 2 | 2017 | 2593 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2006 | 37 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2001 | 1319 | 0.060 |
Why?
|
| Chromatography, Affinity | 2 | 2009 | 52 | 0.060 |
Why?
|
| Child, Preschool | 3 | 2015 | 15005 | 0.060 |
Why?
|
| Apoptosis | 1 | 2013 | 1826 | 0.060 |
Why?
|
| Biogenic Amines | 1 | 2005 | 17 | 0.060 |
Why?
|
| Spine | 2 | 2004 | 150 | 0.060 |
Why?
|
| Cell Communication | 1 | 2006 | 188 | 0.060 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2005 | 16 | 0.060 |
Why?
|
| Mandible | 2 | 2016 | 96 | 0.050 |
Why?
|
| Energy Metabolism | 2 | 2014 | 803 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1604 | 0.050 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2004 | 8 | 0.050 |
Why?
|
| Response Elements | 1 | 2005 | 102 | 0.050 |
Why?
|
| Models, Biological | 1 | 2009 | 1375 | 0.050 |
Why?
|
| Circadian Rhythm | 1 | 2007 | 316 | 0.050 |
Why?
|
| Glutamine | 1 | 2005 | 201 | 0.050 |
Why?
|
| PPAR gamma | 1 | 2004 | 88 | 0.050 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2004 | 30 | 0.050 |
Why?
|
| Infusions, Parenteral | 1 | 2004 | 79 | 0.050 |
Why?
|
| Cerebral Ventricles | 1 | 2004 | 80 | 0.050 |
Why?
|
| Models, Neurological | 1 | 2005 | 211 | 0.050 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2003 | 49 | 0.050 |
Why?
|
| Endocrine System | 1 | 2003 | 18 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 2574 | 0.050 |
Why?
|
| Rats | 3 | 2016 | 3372 | 0.050 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2003 | 60 | 0.050 |
Why?
|
| Adipocytes | 1 | 2004 | 178 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 406 | 0.050 |
Why?
|
| Protein Binding | 2 | 2009 | 1649 | 0.050 |
Why?
|
| Glutathione | 1 | 2003 | 200 | 0.040 |
Why?
|
| Chondroitin ABC Lyase | 1 | 2001 | 1 | 0.040 |
Why?
|
| Biglycan | 1 | 2001 | 6 | 0.040 |
Why?
|
| Tissue Extracts | 1 | 2001 | 8 | 0.040 |
Why?
|
| Decorin | 1 | 2001 | 7 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2004 | 405 | 0.040 |
Why?
|
| Glycosaminoglycans | 1 | 2001 | 43 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2001 | 140 | 0.040 |
Why?
|
| Mutation | 1 | 2015 | 6064 | 0.040 |
Why?
|
| CHO Cells | 1 | 2001 | 151 | 0.040 |
Why?
|
| Cricetinae | 1 | 2001 | 361 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 300 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2004 | 695 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2005 | 996 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2001 | 404 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 1999 | 117 | 0.040 |
Why?
|
| Hypogonadism | 1 | 2003 | 295 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 716 | 0.040 |
Why?
|
| Glucose | 1 | 2004 | 851 | 0.040 |
Why?
|
| Adolescent | 2 | 2016 | 20797 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2001 | 404 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2001 | 732 | 0.040 |
Why?
|
| Transfection | 1 | 2001 | 961 | 0.040 |
Why?
|
| Infant | 1 | 2014 | 13266 | 0.040 |
Why?
|
| Osteolysis | 1 | 2017 | 9 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1999 | 975 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2001 | 1060 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1997 | 252 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2001 | 687 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2018 | 163 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1997 | 421 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2017 | 229 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1997 | 623 | 0.030 |
Why?
|
| Capital Financing | 1 | 2016 | 7 | 0.030 |
Why?
|
| Intersectoral Collaboration | 1 | 2016 | 18 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 780 | 0.030 |
Why?
|
| Periodontal Attachment Loss | 1 | 2016 | 6 | 0.030 |
Why?
|
| Gingiva | 1 | 2016 | 10 | 0.030 |
Why?
|
| Dental Cementum | 1 | 2015 | 1 | 0.030 |
Why?
|
| Alveolar Bone Loss | 1 | 2016 | 6 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 491 | 0.030 |
Why?
|
| Dental Enamel | 1 | 2015 | 18 | 0.030 |
Why?
|
| Periodontitis | 1 | 2016 | 19 | 0.030 |
Why?
|
| Ligation | 1 | 2016 | 133 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 1931 | 0.030 |
Why?
|
| Osseointegration | 1 | 2015 | 4 | 0.030 |
Why?
|
| Sheep, Domestic | 1 | 2015 | 17 | 0.030 |
Why?
|
| Obesity | 2 | 2004 | 2398 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2016 | 298 | 0.030 |
Why?
|
| Proline | 1 | 2015 | 79 | 0.030 |
Why?
|
| Methionine | 1 | 2015 | 95 | 0.030 |
Why?
|
| Phenylalanine | 1 | 2015 | 130 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 1001 | 0.030 |
Why?
|
| Humerus | 1 | 2014 | 16 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 819 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 712 | 0.030 |
Why?
|
| Cell Shape | 1 | 2014 | 68 | 0.030 |
Why?
|
| Disease Management | 1 | 2018 | 553 | 0.030 |
Why?
|
| Diaphyses | 1 | 2014 | 5 | 0.030 |
Why?
|
| Densitometry | 1 | 2013 | 16 | 0.030 |
Why?
|
| Blood Vessels | 1 | 2014 | 91 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 178 | 0.020 |
Why?
|
| Base Sequence | 1 | 1997 | 2729 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 979 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 636 | 0.020 |
Why?
|
| Biomarkers | 2 | 2015 | 3358 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 232 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 777 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 6763 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1997 | 3464 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2014 | 279 | 0.020 |
Why?
|
| Family | 1 | 2016 | 587 | 0.020 |
Why?
|
| Radiography | 1 | 2015 | 740 | 0.020 |
Why?
|
| Peptides | 1 | 2015 | 704 | 0.020 |
Why?
|
| Integrin-Binding Sialoprotein | 1 | 2011 | 2 | 0.020 |
Why?
|
| Video Recording | 1 | 2013 | 193 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 828 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 1120 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2012 | 583 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 1109 | 0.020 |
Why?
|
| Motor Activity | 1 | 2013 | 488 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 556 | 0.020 |
Why?
|
| Collagen Type X | 1 | 2009 | 2 | 0.020 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2009 | 6 | 0.020 |
Why?
|
| Cytokines | 1 | 2015 | 1332 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2009 | 140 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2008 | 52 | 0.020 |
Why?
|
| Incidence | 1 | 2016 | 3321 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 418 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 358 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3391 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 20816 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 6165 | 0.010 |
Why?
|
| Spleen | 1 | 2004 | 258 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 2003 | 54 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 2004 | 160 | 0.010 |
Why?
|
| Receptors, Corticotropin | 1 | 2002 | 1 | 0.010 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2002 | 6 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 2003 | 79 | 0.010 |
Why?
|
| Cysteine | 1 | 2003 | 137 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 242 | 0.010 |
Why?
|
| STAT3 Transcription Factor | 1 | 2004 | 226 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 9978 | 0.010 |
Why?
|
| Reproduction | 1 | 2003 | 210 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 10956 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 951 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2016 | 17538 | 0.010 |
Why?
|